Lumentum Holdings Inc. (LITE) Stock Forecast
Data as of Oct 31, 2026Technology · Current price $837.81 (-9.02%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 2, 2026 | Ruben Roy | Stifel Nicolaus | $800.00 | -4.5% |
| Feb 5, 2026 | Tom O'Malley | Barclays | $475.00 | -43.3% |
| Feb 4, 2026 | Christopher Rolland | Susquehanna | $550.00 | -34.4% |
| Feb 4, 2026 | Vijay Rakesh | Mizuho Securities | $525.00 | -37.3% |
| Feb 4, 2026 | Ryan Koontz | Needham | $550.00 | -34.4% |
| Jan 22, 2026 | Christopher Rolland | Susquehanna | $420.00 | -49.9% |
| Jan 15, 2026 | Tom O'Malley | Barclays | $365.00 | -56.4% |
| Jan 8, 2026 | Alex Henderson | Needham | $470.00 | -43.9% |
| Dec 4, 2025 | Mike Genovese | Rosenblatt Securities | $380.00 | -54.6% |
| Nov 24, 2025 | Alex Henderson | Needham | $290.00 | -65.4% |
| Nov 5, 2025 | Ruben Roy | Stifel Nicolaus | $220.00 | -73.7% |
| Nov 5, 2025 | George Notter | Wolfe Research | $240.00 | -71.4% |
| Nov 5, 2025 | Alex Henderson | Needham | $235.00 | -72.0% |
| Nov 5, 2025 | Meta Marshall | Morgan Stanley | $190.00 | -77.3% |
| Oct 10, 2025 | Meta Marshall | Morgan Stanley | $145.00 | -82.7% |
| Sep 9, 2025 | Tom O'Malley | Barclays | $165.00 | -80.3% |
| Aug 13, 2025 | Tom O'Malley | Barclays | $135.00 | -83.9% |
| Aug 12, 2025 | Christopher Rolland | Susquehanna | $125.00 | -85.1% |
| May 7, 2025 | Tim Savageaux | Northland Securities | $80.00 | -90.5% |
| May 7, 2025 | Tom O'Malley | Barclays | $75.00 | -91.0% |
Top Analysts Covering LITE
LITE vs Sector & Market
| Metric | LITE | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.38 | 2.39 | 2.41 |
| Analyst Count | 21 | 14 | 19 |
| Target Upside | +33.2% | +3582.4% | +21.5% |
| P/E Ratio | 155.05 | 40.30 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-06-28 | $4.38B | $5.06B | $5.78B | 16 |
| 2027-09-27 | $1.42B | $1.49B | $1.57B | 11 |
| 2027-12-27 | $1.51B | $1.58B | $1.66B | 11 |
| 2028-03-27 | $1.60B | $1.68B | $1.77B | 5 |
| 2028-06-27 | $1.68B | $1.76B | $1.85B | 5 |
| 2028-06-28 | $7.15B | $7.25B | $7.36B | 12 |
| 2028-09-27 | $957M | $1.00B | $1.06B | 5 |
| 2028-12-27 | $995M | $1.04B | $1.10B | 5 |
| 2029-03-27 | $1.01B | $1.06B | $1.12B | 7 |
| 2029-06-27 | $1.06B | $1.11B | $1.17B | 7 |
| 2029-06-28 | $3.67B | $4.21B | $4.87B | 8 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-06-28 | $12.96 | $16.10 | $20.21 | 12 |
| 2027-09-27 | $4.57 | $4.86 | $5.20 | 5 |
| 2027-12-27 | $4.90 | $5.20 | $5.56 | 5 |
| 2028-03-27 | $5.11 | $5.43 | $5.80 | 6 |
| 2028-06-27 | $5.41 | $5.75 | $6.14 | 6 |
| 2028-06-28 | $13.23 | $23.60 | $35.39 | 5 |
| 2028-09-27 | $2.42 | $2.57 | $2.75 | 6 |
| 2028-12-27 | $2.54 | $2.70 | $2.89 | 6 |
| 2029-03-27 | $2.56 | $2.73 | $2.91 | 5 |
| 2029-06-27 | $2.69 | $2.86 | $3.06 | 5 |
| 2029-06-28 | $9.03 | $10.86 | $13.07 | 2 |
Frequently Asked Questions
What is the analyst consensus for LITE?
The consensus among 21 analysts covering Lumentum Holdings Inc. (LITE) is Buy with an average price target of $1092.17.
What is the highest price target for LITE?
The highest price target for LITE is $800.00, set by Ruben Roy at Stifel Nicolaus on 2026-03-02.
What is the lowest price target for LITE?
The lowest price target for LITE is $38.00, set by Tom O'Malley at Barclays on 2024-05-07.
How many analysts cover LITE?
21 analysts have issued ratings for Lumentum Holdings Inc. in the past 12 months.
Is LITE a buy or sell right now?
Based on 21 analyst ratings, LITE has a consensus rating of Buy (2.38/5) with a +33.2% upside to the consensus target of $1092.17.
What are the earnings estimates for LITE?
Analysts estimate LITE will report EPS of $16.10 for the period ending 2027-06-28, with revenue estimated at $5.06B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.